Home  |  Publications  |  Conferences   |  Join  |  Contact
ISSN: 1948-5956

Journal of Cancer Science & Therapy

Open Access
home » cancer-science-therapy

Upcoming Special Issues

Special issue entitled: "Cancer Research: Clinical & Experimental" has been edited by
Editor Image

Jimmy Thomas Efird, PhD
Center for Health of Vulnerable Populations
University of North Carolina

University Logo
Special issue entitled: "Novel Targeted Therapies for Patients with Ovarian Cancer" has been edited by
Editor Image

Samir A Farghaly, M.D.PhD
Obstetrics and Gynecology
Cornell University

University Logo
Read More»

About the Journal

Impact Factor: 4.203*
H-Factor: 7
Index Copernicus Value: 5.13
Oncology is a study of oncogenes which causes cancer. Whereas cancer encompassing more than 100 diseases which initiates with the abnormal cell growth. Cells become cancerous because of deoxyribonucleic acid which can be inherited due to environmental conditions or habits. Cancer cells causes tumor which replaces the normal tissue and circulates through other tissues which is called metastasis. Different types of cancer include lungs cancer, breast cancer, ovarian cancer and skin cancer etc. which provoke the scientist to carry out the research and methodologies to cure the disease. Novel research in cancer brings advancement in drug research and development, which enhances the scientific knowledge. 
Journal of Cancer Sciences and therapy is a peer reviewed journal serving the International Scientific Community. This journal offers an open access platform to the authors to publish their research outcome and thus help in promoting Cancer and Oncology research..
Journal of Cancer Science and Therapy is an Open Access publishing that aims to focus on the most complete and reliable source of information on discoveries and current developments as original article, review articles, case reports, short communications, etc. related to Cancer research and therapy and provides free online access to the researchers worldwide.
This top best scholarly journal is using Editorial Manager® System for online manuscript submission, review and tracking. Editorial board members of the JCST or outside experts review manuscripts; at least two independent reviewer’s approval followed by the editor is required for the acceptance of any citable manuscript.
OMICS Group International is a leading Open Access publisher that publishes more than 500+ peer-reviewed Open Access Journals and organizes over 300+ International Conferences globally with the support of nearly 1000 International Societies. OMICS Publishing Group journals cater to over 3 million readers with the support of 30000 eminent personalities as editorial board members.
Journal of Cancer Science and Therapy is supporting 5th World congress on Cancer Therapy which is going to be held during September 28-30, 2015, at Atlanta, USA. The theme of the conference is “Emerging Therapeutic advances in cancer therapy”.
SSubmit manuscript at www.editorialmanager.com/cancerscience/ or send as an e-mail attachment to the Editorial Office at editor.jcst@omicsonline.org
*Unofficial 2013 Impact Factor was established by dividing the number of articles published in 2011 and 2012 with the number of times they are cited in 2013 based on Google search and the Scholar Citation Index database. If ‘X’ is the total number of articles published in 2011 and 2012, and ‘Y’ is the number of times these articles were cited in indexed journals during 2013 than, impact factor = Y/X
Aims and Scope



Recently published articles

Nanosomal Paclitaxel Lipid Suspension Demonstrates Higher Response Rates Compared to Paclitaxel in Patients with Metastatic Breast Cancer

Ateeq Ahmad, Saifuddin Sheikh, Shoukath M Ali, Mahesh Paithankar, Ajay Mehta, Rajnish Nagarkar, Srinivasan Krishnan, Anup Majumdar, Kalyan K Mukherjee, Jitendra K Singh, Shanti P Shrivastav, Chiradoni T Satheesh, Tanveer Maksud, Suraj Pawar, Satish R Sonawane, Satish Kamath, Rajesh CN, Hanmant V Barkate and Imran Ahmad

Knockdown of the Inhibitor of Apoptosis BRUCE Sensitizes Resistant Breast Cancer Cells to Chemotherapeutic Agents

Jason B Garrison, Chunmin Ge, Lixiao Che, Derek A Pullum, Guang Peng, Sohaib Khan, Nira Ben-Jonathan, Jiang Wang and Chunying Du

Clinical Features of the Gastric Signet Ring Cell Carcinoma Including CA 19-9, CEA and CRP Levels

Bulent Kaya, Hasan Abuoglu, Cengiz Eris, Mehmet Kamil Yildiz, Orhan Bat, Mehmet Odabasi, Nuriye Esen Bulut, Alper Şahbaz, Aziz Şener, Azamet Çezik and Umit Topaloglu

Characterization of Kallireins and microRNAs in Urine Sediment for the Discrimination of Prostate Cancer from Benign Prostatic Hyperplasia

Maria G. Egidi, Gabriella Guelfi, Giovanni Cochetti, Giulia Poli, Francesco Barillaro, Danilo Zampini, Luca Mechelli and Ettore Mearini

© 2008-2015 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version